{"id":"nadroparin","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["nadroparin is a low molecular weight heparin","Low moleculor weight hepatin","Fraxiparine","Fraxiparin"],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T18:27:08.964085","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=nadroparin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:08:21.550899+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:08:28.123225+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=nadroparin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:08:28.920770+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Antithrombin-III activator","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:08:29.476936+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2109204/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:08:29.388167+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-27T23:56:31.773Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:08:31.245739+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Deep venous thrombosis","diseaseId":"deep-venous-thrombosis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["pubmed(536)"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07140211","phase":"PHASE3","title":"Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis","status":"RECRUITING","sponsor":"Marc Blondon","startDate":"2025-10-15","conditions":"Venous Thromboembolism (VTE), Postpartum","enrollment":9200},{"nctId":"NCT06845423","phase":"PHASE4","title":"Prevention of Postpartum Venous Thromboembolism in Women at Intermediate Risk","status":"RECRUITING","sponsor":"University Hospital, Brest","startDate":"2025-05-16","conditions":"Venous Thromboembolism (VTE), Post Partum Women","enrollment":2400},{"nctId":"NCT04536272","phase":"PHASE3","title":"Reduced Anticoagulation Targets in ECLS (RATE)","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2020-10-01","conditions":"Heart Failure, Respiratory Failure, Extracorporeal Membrane Oxygenation","enrollment":330},{"nctId":"NCT04645550","phase":"PHASE4","title":"Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）","status":"COMPLETED","sponsor":"Northern Jiangsu People's Hospital","startDate":"2020-11-22","conditions":"Cirrhosis, Splenectomy; Status, Venous Thrombosis","enrollment":120},{"nctId":"NCT02987946","phase":"NA","title":"Leiden Trial in Prevention of Post-Operative ThromboEmbolic Events","status":"COMPLETED","sponsor":"Leiden University Medical Center","startDate":"2016-12","conditions":"Deep-Venous Thrombosis","enrollment":280},{"nctId":"NCT06494878","phase":"PHASE3","title":"The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-04","conditions":"Venous Thromboembolism, Postpartum Period, Aspirin","enrollment":8805},{"nctId":"NCT04507178","phase":"PHASE2","title":"Improving Outcome in Subarachnoid Hemorrhage wIth Nadroparine","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2022-02-02","conditions":"Aneurysmal Subarachnoid Hemorrhage, Delayed Cerebral Ischemia","enrollment":100},{"nctId":"NCT05957146","phase":"","title":"Kinetics of Extracellular Vesicles in Hemodialysis","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-11-07","conditions":"End-stage Kidney Disease","enrollment":6},{"nctId":"NCT04508855","phase":"","title":"Management of Atrial Fibrillation in Patients With Cancer (MAFIC Study)","status":"WITHDRAWN","sponsor":"AHEPA University Hospital","startDate":"2020-08-01","conditions":"Cancer, Atrial Fibrillation","enrollment":""},{"nctId":"NCT04066764","phase":"PHASE3","title":"Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-08","conditions":"Venous Thromboembolism","enrollment":200},{"nctId":"NCT04067505","phase":"PHASE3","title":"Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-18","conditions":"May-Thurner Syndrome","enrollment":224},{"nctId":"NCT06319131","phase":"NA","title":"Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVT","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2024-05-01","conditions":"Portal Vein Thrombosis","enrollment":84},{"nctId":"NCT04373707","phase":"PHASE4","title":"Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19","status":"COMPLETED","sponsor":"Central Hospital, Nancy, France","startDate":"2020-05-13","conditions":"COVID, Thrombosis, Pulmonary Embolism","enrollment":1000},{"nctId":"NCT05926518","phase":"","title":"Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients","status":"COMPLETED","sponsor":"Rijnstate Hospital","startDate":"2020-11-01","conditions":"Critical Illness, Therapeutic Drug Monitoring, Venous Thromboembolism","enrollment":62},{"nctId":"NCT05621915","phase":"","title":"Nadroparin Pharmacokinetics in Different Stages of COVID-19","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2021-02-01","conditions":"Thrombosis, Nadroparin, COVID-19","enrollment":43},{"nctId":"NCT03005444","phase":"NA","title":"Anticoagulation for Advanced Cirrhotic Patients After TIPS","status":"UNKNOWN","sponsor":"Air Force Military Medical University, China","startDate":"2017-06-14","conditions":"Liver Cirrhosis","enrollment":254},{"nctId":"NCT04976543","phase":"PHASE4","title":"Safety of Anticoagulant Therapy After Endoscopic Treatment","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2020-02-01","conditions":"Cirrhosis, Portal Vein Thrombosis, Esophageal and Gastric Varices","enrollment":86},{"nctId":"NCT05545475","phase":"","title":"Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2022-01-01","conditions":"Anticoagulants and Bleeding Disorders, Tissue Adhesion, Gastric Varices Bleeding","enrollment":100},{"nctId":"NCT01828697","phase":"PHASE4","title":"Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-04-24","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1110},{"nctId":"NCT04982055","phase":"PHASE4","title":"Intravenous Versus Subcutaneous Administration of Low Molecular Weight Heparin for Thromboprophylaxis in Critically Ill Patients","status":"COMPLETED","sponsor":"Clinique Saint Pierre Ottignies","startDate":"2015-04-08","conditions":"Critical Illness","enrollment":60},{"nctId":"NCT04173429","phase":"PHASE4","title":"Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis","status":"COMPLETED","sponsor":"Qilu Hospital of Shandong University","startDate":"2017-01-01","conditions":"Liver Cirrhosis, Portal Vein Thrombosis","enrollment":64},{"nctId":"NCT03671174","phase":"NA","title":"Immunosuppressant Regimens for Living Fetuses Study","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2019-08-02","conditions":"Undifferentiated Connective Tissue Disease, Recurrent Pregnancy Loss","enrollment":420},{"nctId":"NCT01727427","phase":"","title":"Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients","status":"COMPLETED","sponsor":"G. d'Annunzio University","startDate":"2012-11","conditions":"Unsuspected Pulmonary Embolism","enrollment":695},{"nctId":"NCT02247414","phase":"PHASE4","title":"Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection","status":"COMPLETED","sponsor":"Yangzhou University","startDate":"2014-09","conditions":"Cirrhosis, Hypertension, Status;Splenectomy","enrollment":124},{"nctId":"NCT03841396","phase":"PHASE4","title":"A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.","status":"COMPLETED","sponsor":"Aspen Global Incorporated","startDate":"2016-06-02","conditions":"Injection Site Reaction","enrollment":15},{"nctId":"NCT02238444","phase":"PHASE4","title":"Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy","status":"UNKNOWN","sponsor":"Yangzhou University","startDate":"2014-09-01","conditions":"Cirrhosis, Hypertension, Venous Thrombosis","enrollment":60},{"nctId":"NCT01431456","phase":"PHASE3","title":"Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery","status":"COMPLETED","sponsor":"Martini Hospital Groningen","startDate":"2013-09","conditions":"Venous Thromboembolism","enrollment":148},{"nctId":"NCT00421538","phase":"PHASE3","title":"Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2008-01","conditions":"Distal (Calf) Deep-vein Thrombosis","enrollment":260},{"nctId":"NCT00312013","phase":"PHASE3","title":"Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05","conditions":"Thrombosis, Venous","enrollment":503},{"nctId":"NCT02526303","phase":"NA","title":"Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis","status":"WITHDRAWN","sponsor":"Air Force Military Medical University, China","startDate":"","conditions":"Liver Cirrhosis, Portal Vein Thrombosis, Anticoagulation","enrollment":""},{"nctId":"NCT02957877","phase":"PHASE4","title":"LMWH Infusion as Anticoagulation for Home HD","status":"UNKNOWN","sponsor":"Alice Ho Miu Ling Nethersole Hospital","startDate":"2016-03","conditions":"Endstage Renal Disease","enrollment":12},{"nctId":"NCT01542762","phase":"NA","title":"Pot-Cast: Thrombosis Prophylaxis During Plaster Cast Lower Leg Immobilisation","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-03","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT01542723","phase":"NA","title":"Pot-Kast: Thrombosis Prophylaxis After Knee Arthroscopy","status":"COMPLETED","sponsor":"Suzanne C. Cannegieter, MD PhD","startDate":"2012-05","conditions":"Deep Venous Thrombosis, Pulmonary Embolism","enrollment":1500},{"nctId":"NCT00700895","phase":"PHASE3","title":"Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose","status":"UNKNOWN","sponsor":"National University Hospital, Singapore","startDate":"2006-08","conditions":"Indications for Warfarin Therapy","enrollment":320},{"nctId":"NCT00827554","phase":"PHASE2, PHASE3","title":"The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma","status":"COMPLETED","sponsor":"Eastern Hepatobiliary Surgery Hospital","startDate":"2008-12","conditions":"Hepatocellular Carcinoma","enrollment":100},{"nctId":"NCT00843492","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-12","conditions":"Thrombosis, Venous","enrollment":1351},{"nctId":"NCT02630095","phase":"PHASE4","title":"The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2015-12","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":96},{"nctId":"NCT02398357","phase":"PHASE4","title":"The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2015-03","conditions":"Portal Vein Thrombosis, Liver Cirrhosis","enrollment":96},{"nctId":"NCT01064362","phase":"","title":"Hemorrhage Risk Prescribed Arixtra","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-01","conditions":"Thrombosis, Venous","enrollment":13442},{"nctId":"NCT01164046","phase":"PHASE3","title":"Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism","status":"TERMINATED","sponsor":"University Medical Center Groningen","startDate":"2010-08","conditions":"Venous Thromboembolism, Neoplasms","enrollment":56},{"nctId":"NCT02295150","phase":"PHASE4","title":"Prophylaxis of Venous Thromboembolism After Bariatric Surgery","status":"UNKNOWN","sponsor":"Rijnstate Hospital","startDate":"2013-03","conditions":"Morbid Obesity, Thromboembolism, Bypass Complications","enrollment":50},{"nctId":"NCT01267305","phase":"NA","title":"The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery","status":"COMPLETED","sponsor":"Shanghai Zhongshan Hospital","startDate":"2011-01","conditions":"Lung Neoplasms, Esophageal Neoplasms, Venous Thromboembolism","enrollment":362},{"nctId":"NCT01980849","phase":"PHASE3","title":"Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer","status":"UNKNOWN","sponsor":"Shengqing Li","startDate":"2013-11","conditions":"Lung Cancer","enrollment":272},{"nctId":"NCT01862978","phase":"PHASE4","title":"Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke","status":"UNKNOWN","sponsor":"University Hospital, Martin","startDate":"2013-05","conditions":"Acute Ischemic Stroke","enrollment":150},{"nctId":"NCT00881088","phase":"PHASE2, PHASE3","title":"Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures","status":"UNKNOWN","sponsor":"Red Cross Hospital Beverwijk","startDate":"2009-04","conditions":"Deep Vein Thrombosis, Pulmonary Embolism","enrollment":669},{"nctId":"NCT01531829","phase":"PHASE4","title":"Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD","status":"UNKNOWN","sponsor":"Beijing Chao Yang Hospital","startDate":"2009-07","conditions":"Pulmonary Thromboembolisms, Pulmonary Embolism","enrollment":460},{"nctId":"NCT01523652","phase":"","title":"Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients","status":"COMPLETED","sponsor":"Azienda Ospedaliera San Giovanni Battista","startDate":"2007-11","conditions":"Genital Diseases, Female, Ovarian Neoplasms, Urogenital Neoplasms","enrollment":29},{"nctId":"NCT00951574","phase":"PHASE3","title":"Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)","status":"COMPLETED","sponsor":"Italfarmaco","startDate":"2003-10","conditions":"Advanced Cancer, Metastatic Cancer","enrollment":1166},{"nctId":"NCT01097148","phase":"PHASE4","title":"Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients","status":"COMPLETED","sponsor":"St. Antonius Hospital","startDate":"2009-11","conditions":"Obese, Atracurium, Cefazolin","enrollment":20},{"nctId":"NCT01019655","phase":"PHASE3","title":"Heparin for Pregnant Women With Thrombophilia","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2010-01","conditions":"Pregnancy and Thrombophilia","enrollment":300},{"nctId":"NCT00286273","phase":"PHASE4","title":"Safety and Efficacy of the Use of Regional Anticoagulation With Citrate in Continuous Venovenous Hemofiltration","status":"COMPLETED","sponsor":"Onze Lieve Vrouwe Gasthuis","startDate":"2003-03","conditions":"Kidney Failure, Acute","enrollment":215},{"nctId":"NCT00965328","phase":"PHASE4","title":"Nadroparin Anticoagulation for Continuous Venovenous Hemofiltration","status":"COMPLETED","sponsor":"Onze Lieve Vrouwe Gasthuis","startDate":"2007-02","conditions":"Kidney, Acute Renal Failure, Multiple Organ Failure","enrollment":14},{"nctId":"NCT00796692","phase":"PHASE4","title":"Nadroparin for the Initial Treatment of Pulmonary Thromboembolism","status":"COMPLETED","sponsor":"Beijing Chao Yang Hospital","startDate":"2002-06","conditions":"Pulmonary Embolism, Thromboembolism, Vascular Diseases","enrollment":274},{"nctId":"NCT00669721","phase":"NA","title":"OPG and RANKL Plasma Level After Administration of Unfractionated Heparin (UFH) and Low-Molecular-Weight Heparin (LMWH) in Hemodialysis","status":"UNKNOWN","sponsor":"IRCCS Azienda Ospedaliero-Universitaria di Bologna","startDate":"2008-03","conditions":"Renal Failure, Hemodialysis","enrollment":40},{"nctId":"NCT00303407","phase":"","title":"Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care","status":"TERMINATED","sponsor":"University Hospital, Geneva","startDate":"2001-01","conditions":"Cancer, Venous Thromboembolism","enrollment":""}],"_emaApprovals":[],"_faersSignals":[{"count":127,"reaction":"DIARRHOEA"},{"count":127,"reaction":"DYSPNOEA"},{"count":126,"reaction":"OFF LABEL USE"},{"count":123,"reaction":"PNEUMONIA"},{"count":120,"reaction":"PYREXIA"},{"count":112,"reaction":"ANAEMIA"},{"count":104,"reaction":"DRUG INTERACTION"},{"count":86,"reaction":"VOMITING"},{"count":82,"reaction":"HYPONATRAEMIA"},{"count":78,"reaction":"MATERNAL EXPOSURE DURING PREGNANCY"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL2109204"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":537,"therapeuticAreas":["Cardiovascular"],"biosimilarFilings":[],"recentPublications":[{"date":"2026 Mar","pmid":"41908993","title":"Observation of the Clinical Efficacy of Enoxaparin Sodium and Nadroparin Calcium in Preventing Lower Limb DVT after ACLR.","journal":"Indian journal of orthopaedics"},{"date":"2026","pmid":"41675333","title":"Hepatic arterial infusion chemotherapy combined with targeted immunotherapy and anticoagulation for hepatocellular carcinoma with right atrial tumor thrombus: a case report.","journal":"Translational gastroenterology and hepatology"},{"date":"2026","pmid":"41615959","title":"Extended thrombotic prophylaxis in COVID-19 early discharge: A retrospective cohort study.","journal":"PloS one"},{"date":"2026 Jan 22","pmid":"41498425","title":"Discovery of a Piperazine-Based Quaternary Ammonium Macrocycle as a Universal Reversal Agent for Heparin Anticoagulants.","journal":"Journal of medicinal chemistry"},{"date":"2026 Jan","pmid":"41270507","title":"Exploring anti-Xa activity and its correlation with C-Reactive Protein in Intensive Care Unit patients receiving a therapeutic dosage of nadroparin.","journal":"Thrombosis research"}],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"nadroparin","genericName":"nadroparin","companyName":"Onze Lieve Vrouwe Gasthuis","companyId":"onze-lieve-vrouwe-gasthuis","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:08:31.245739+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}